PPARG and metabolic dysfunction-associated steatohepatitis: In conclusion, this is the first report that Alisol B alleviated hepatocyte lipid accumulation and lipotoxicity via regulating RARα-PPARγ-CD36 cascade, thereby attenuating NASH in mice.